Psycho-social impact of positive human papillomavirus testing in Jujuy, Argentina results from the Psycho-Estampa study

• Autores: Arrossi, Silvina; Almonte, Maribel; Herrero, Rolando; Gago, Juan; Sánchez Antelo, Victoria; Szwarc, Lucila; Thouyaret, Laura; Paolino, Melisa; Weisner, Carolina
• Año de publicación: 2020
• Idioma: inglés
• Tipo de recurso: libro
• Fuente: Prev Med Rep. 2020 Mar 5;18:101070.
• Materia: HPV; Pruebas de ADN del Papillomavirus Humano; Jujuy; Argentina; AMERICA LATINA; Impacto Psicosocial
• Institución: Centro de Estudios de Estado y Sociedad

Fil: Arrossi, Silvina. CEDES. Centro de Estudio de Estado y Sociedad. Área de Salud, Economía y Sociedad. Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET); Argentina.
Fil: Almonte, Maribel. International Agency for Research on Cancer/World Health Organization (IARC-WHO); Francia.
Fil: Herrero, Rolando. International Agency for Research on Cancer/World Health Organization (IARC-WHO); Francia.
Fil: Gago, Juan. School of Medicine. New York University-NYU; Estados Unidos.
Fil: Sánchez Antelo, Victoria. CEDES. Centro de Estudios de Estado y Sociedad. Área de Salud, Economía y Sociedad; Argentina.
Fil: Szwarc, Lucila. CEDES. Centro de Estudios de Estado y Sociedad. Área de Salud, Economía y Sociedad. Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET); Argentina.
Fil: Thouyaret, Laura. Instituto Nacional del Cáncer. Programa Nacional de Prevención de Cáncer Cervicouterino; Argentina.
Fil: Paolino, Melisa. CEDES. Centro de Estudios de Estado y Sociedad. Área de Salud, Economía y Sociedad; Argentina.
Fil: Weisner, Carolina. Instituto Nacional de Cancerología; Colombia.
Human papillomavirus (HPV) testing can have a negative impact on women’s lives which might also result in abandoning the follow-up and treatment process. This study measured the psycho-social impact of HPV-positivity among HPV-tested women from Jujuy, Argentina, a middle-low income setting. In this cross-sectional study (2015–2016), the psycho-social impact of HPV-positivity was measured using the Psycho-Estampa Scale, specifically designed and validated to be used in screening contexts. We measured mean scores for each of the five scale domains, and the Overall Impact score (Values from 1: No impact to 4: Heavy impact). We compared scores according to cytology triage diagnosis using ordinal logistic regression. A total of 163 HPV-positive women were recruited at the Centro Carlos Alvarado hospital and included in the study sample; of these, 124 (76.1%) had normal triage cytologies. The overall Impact score was between low and moderate (mean:2.56, SD:0.65). The highest psycho-social impact was measured in the Worries about cancer and treatment domain (mean score:3.60, SD:0.60), followed by Sexuality domain (mean:2.50; SD:1.00). The Uncertainty about information provided by health providers domain had the lowest mean score (mean:2.14, SD:0.73). Compared to women with normal cytologies (n = 124), women with abnormal cytologies (n = 39) had a higher likelihood of greater overall Psycho-social Impact (OR: 2.91; p = 0.0036). No statistically significant differences were found in scores of specific domains according to cytology results. It is important to devise specific counseling interventions to reduce the psycho-social impact of HPV-Testing as primary screening and its potential effect on completion of the diagnosis/ treatment process.